Edwards Lifesciences | EW - 营业费用

股票价格

84.15

每天变化

4.43 5.56%

每月一次

1.79%

每年

10.67%

Q2 预测

82.35

金融业

USD

USD 13.7B

现金及等价物

USD 2.4B

USD 362.6M

USD 6.74B

USD 1.81B

USD 600M

USD 514.7M

USD 70.1M

15.8K

EPS每股收益

USD 0.78

股本和储备

USD 10.34B

USD 1.29B

债务利息支出

USD 35.9M

USD 56.3M

USD 600M

USD 49.08B

USD 380.7M

USD 1.13B

USD 514.7M

普通股股本

USD 580.7M

26.87

USD 348.4M

USD 1.65B

销售和管理费用

USD 522.2M

USD 1.13B

贸易债权人

USD 227.5M

应收帐款人

USD 912.1M

	营业费用	更改		日
Abbott	USD 9.31B		104M	2026-03
Artivion	USD 111.2M		9.45M	2025-12
AtriCure	USD 138.01M		3.95M	2025-12
Baxter International	USD 3.19B		554.4M	2025-12
Becton, Dickinson and Co.	USD 4.59B		476M	2025-12
Boston Scientific	USD 4.04B		18M	2025-12
Cooper Companies	USD 811.3M		113.5M	2025-12
Dexcom	USD 936.6M		30.2M	2025-12
Edwards Lifesciences	USD 1.13B		65.4M	2026-03
Globus Medical	USD 645.11M		241.46M	2025-12
ICU Medical	USD 514.62M		4.48M	2025-12
Inogen	USD 49.14M		665K	2024-09
Insulet	USD 637.5M		48.9M	2025-12
Integra LifeSciences	USD 368.92M		668.65M	2025-12
Intuitive Surgical	USD 1.91B		89.8M	2026-03
J&J	USD 17.44B		1.53B	2026-03
Masimo	USD 328.6M		181.6M	2025-12
Medtronic	USD 7.28B		16M	2025-12
Merit Medical Systems	USD 339.74M		1.8M	2025-12
Stryker	USD 5.2B		505M	2025-12
Tandem Diabetes Care	USD 282.09M		9.97M	2025-12
Teleflex	USD 532.64M		3.29B	2025-12
Zimmer Biomet Holdings	USD 1.94B		277.8M	2025-12